Abbott Laboratories (ABT) Construction in Progress (2009 - 2025)

Abbott Laboratories has disclosed Construction in Progress across 17 years of filings, most recently posting $2.6 billion for Q4 2025.

• Construction in Progress for Q4 2025 came in at $2.6 billion, up 3.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.6 billion (up 3.18% YoY), and the FY2025 annual result was $2.6 billion, up 3.18% from the prior year.
• Construction in Progress came in at $2.6 billion for Q4 2025 at Abbott Laboratories, up from $2.5 billion in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $2.6 billion in Q4 2025 to a low of $1.3 billion in Q4 2021.
• The 5-year median for Construction in Progress is $2.1 billion (2023), against an average of $2.0 billion.
• Across the five-year window, Construction in Progress retreated 3.91% in 2021 and soared 39.08% in 2023, its largest moves.
• Abbott Laboratories' Construction in Progress stood at $1.3 billion in 2021, then gained by 13.8% to $1.5 billion in 2022, then jumped by 39.08% to $2.1 billion in 2023, then advanced by 20.54% to $2.5 billion in 2024, then advanced by 3.18% to $2.6 billion in 2025.
• The last three Construction in Progress figures came in at $2.6 billion (Q4 2025), $2.5 billion (Q4 2024), and $2.1 billion (Q4 2023), per Business Quant data.